CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 02, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and ...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world ...
With the school start in Baden-Wuerttemberg the summer travel season ends in whole Germany. At the end of the summer, CENTOGENE and Lufthansa are taking a positive interim balance of the test centers ...
Centogene, a commercial-stage company, and Fujirebio Europe announced to have entered a partnership to leverage Lumipulse G technology for large-scale COVID-19 antigen testing with further deployment ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
(RTTNews) - Shares of Centogene N.V. (CNTG) are rising more than 11% Monday morning after the company said it has received Emergency Use Authorization (EUA) from the FDA for 'CentoSure', the company's ...
World leader and trusted partner in rare diseases releases enhanced Whole Exome Sequencing (WES) solution to improve diagnosis in complex and unsolved patient cases NEW CentoXome® provides ...
Publication demonstrates genome sequencing as the optimal standard for genetic testing Study presents the largest cohort of its kind with over 1,000 index cases Genome sequencing minimizes stepwise ...
Centogene has raised $28 million to expand its presence in the U.S. and China. The financing sees the rare disease genetic diagnostic specialist turn its back on the venture capital-free approach it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results